For example, it has been demonstrated that low-avidity CTLs can capture peptide-major histocompatibility complexes from tumor cells via trogocytosis, decreasing Ag density on tumor cells and thereby making them poor targets for high-avidity CTLs (53). The gene discussed is RENBP; the disease is neoplasm.